000 02305 a2200637 4500
005 20250515092443.0
264 0 _c20080311
008 200803s 0 0 eng d
022 _a0006-4971
024 7 _a10.1182/blood-2007-08-107839
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFox, Elizabeth
245 0 0 _aPhase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma.
_h[electronic resource]
260 _bBlood
_cJan 2008
300 _a566-73 p.
_bdigital
500 _aPublication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
650 0 4 _aAbdominal Pain
_xchemically induced
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aArsenic Trioxide
650 0 4 _aArsenicals
_xadverse effects
650 0 4 _aChild
650 0 4 _aChild, Preschool
650 0 4 _aConstipation
_xchemically induced
650 0 4 _aDermatitis
_xdrug therapy
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aHeadache
_xchemically induced
650 0 4 _aHumans
650 0 4 _aHyperglycemia
_xchemically induced
650 0 4 _aInfusions, Intravenous
650 0 4 _aLeukemia, Promyelocytic, Acute
_xcomplications
650 0 4 _aLymphoma
_xcomplications
650 0 4 _aMale
650 0 4 _aNausea
_xchemically induced
650 0 4 _aOxides
_xadverse effects
650 0 4 _aPancreatitis
_xchemically induced
650 0 4 _aPneumonia
_xchemically induced
650 0 4 _aRecurrence
650 0 4 _aTime Factors
650 0 4 _aVomiting
_xchemically induced
650 0 4 _aWater-Electrolyte Balance
_xdrug effects
700 1 _aRazzouk, Bassem I
700 1 _aWidemann, Brigitte C
700 1 _aXiao, Shaun
700 1 _aO'Brien, Michelle
700 1 _aGoodspeed, Wendy
700 1 _aReaman, Gregory H
700 1 _aBlaney, Susan M
700 1 _aMurgo, Anthony J
700 1 _aBalis, Frank M
700 1 _aAdamson, Peter C
773 0 _tBlood
_gvol. 111
_gno. 2
_gp. 566-73
856 4 0 _uhttps://doi.org/10.1182/blood-2007-08-107839
_zAvailable from publisher's website
999 _c17479277
_d17479277